Patent ID: 11903950
Assignee: NEWAVE PHARMACEUTICAL INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 9:
10. The compound according to claim 9, or the N-oxide thereof, or the pharmaceutically acceptable salt, solvate, polymorph, tautomer, stereoisomer, or isotopic form thereof, wherein
Z1 is a bond or (CH2)p;
L is L1 and L1 is bond, and
R9 is 5-7 membered heterocyclyl or 7-10 membered bridged heterocyclyl, each of which is optionally substituted with 1-3 groups selected from halo, —OH, —CN, —COOH, —NH2, —N(CH3)2, —(C1-C4)alkyl, and —(C1-C4)alkoxy.